The development of new therapies based on tissue engineering technologies poses many challenges at all levels, from fundamental science to manufacture, regulation and sale of product into a new and largely untested market. This article discusses some of the major factors influencing the development of tissue engineering from laboratory to clinic, and its emergence as a mainstream cost effective treatment option within the field of regenerative medicine.
No takes yet. Share an insight, caveat, or question.
Christopher W. G. Ansell (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: